The case for underwriting as the new defensible moat in healthcare | Sean Doolan & Emre Karatas (Virtue VC)

Sean Doolan and Emre Karatas from Virtue VC join to discuss their thesis that a new actuarial infrastructure layer is emerging in healthcare and why they're investing behind it.

The starting point is a simple observation: most healthcare risk is either mispriced or unpriced, and the incumbents who could theoretically fix it are structurally prevented from doing so because their business models depend on the mispricing. That creates an opening for a new category of companies that can quote a number, bear the risk, and stand behind their math.

Sean and Emre walk through how they think about this infrastructure layer, with dashboards and workflow tools on top and underwriting as the chassis underneath. RightWise, a portfolio company repricing pharmacy claims at the individual drug level for self-insured SMB employers, serves as a concrete illustration of their thesis.

The conversation also covers where else the thesis applies: ACOs, medical malpractice, surgical centers of excellence, and site of care arbitrage. On go-to-market, Sean and Emre explain why pharmacy is a cleaner starting point than medical, why SMBs are the right initial customer, and why focused execution beats trying to serve the whole market at once.

Sean and Emre wrap by underscoring that actuarial infrastructure is one of the more defensible investment categories in an AI world and what kind of founders Virtue wants to hear from.

For more from Health Tech Nerds, subscribe to our weekly newsletters: healthtechnerds.com/subscribe" target="_blank" rel="noopener noreferrer">https://www.healthtechnerds.com/subscribe